Filter By “Lab / Genomic Data”

An overview of the value health data linkage can bring to consulting & professional services firms and their clients, along with 7 case studies.

In Part 1 of this article, we discussed the evolving scientific landscape of disclosure risk in genetics data. In Part 2, we explore the legislative outcomes of this development. In particular, we will analyze the requirements of the HIPAA Omnibus Rule (2013) and propose a framework for how privacy experts should apply these in practice.

Learn how advances in genomics impacts genomic data privacy and how studies can adjust to meet new requirements.

Learn how genomic data has evolved through time and what are predictions are for how it will evolve in the future.

A molecular diagnostics company developed a blood test to support treatment selection for patients with advanced non-small cell lung cancer (NSCLC).

Despite high effectiveness of COVID-19 vaccines in the real-world, there have been cases of fully vaccinated patients contracting COVID.

Over the last few years, connecting health data is evolving from innovation to standard practice. Pharmaceutical companies, health systems, government, payers, and analytics platforms connect data, creating a robust picture of patient health, to accelerate research, improve care, and lower healthcare costs.

This time, we’ll review new data available through Datavant’s ecosystem partners and its value in answering specific questions. As partners continue to join our ecosystem, there are more opportunities for health systems, insurers and biopharma companies to connect data that completes the picture of patient health.

Explore health data available through Datavant’s ecosystem partners and its value in accelerating research, improving care, and more.